Microencapsulation as a novel delivery method for the potential antidiabetic drug, Probucol

QR Code

Microencapsulation as a novel delivery method for the potential antidiabetic drug, Probucol

Introduction: In previous studies, we successfully designed complex multicompartmental microcapsules as a platform for the oral targeted delivery of lipophilic drugs in type 2 diabetes (T2D). Probucol (PB) is an antihyperlipidemic and antioxidant drug with the potential to show benefits in T2D. We a...

Full description

Bibliographic Details
Main Authors:	Mooranian, Armin, Negrulj, Rebecca, Chen-Tan, Nigel, Al-Sallami, H., Fang, Zhongxiang, Mukkur, Trilochan, Mikov, M., Golocorbin-Kon, S., Fakhoury, M., Watts, G., Matthews, V., Arfuso, Frank, Al-Salami, Hani
Format:	Journal Article
Published:	Dove Medical Press Ltd. 2014
Subjects:	artificial cell microencapsulation Probucol anti-inflammatory diabetes antioxidant
Online Access:	http://hdl.handle.net/20.500.11937/7195

Similar Items

Probucol Release from Novel Multicompartmental Microcapsules for the Oral Targeted Delivery in Type 2 Diabetes
by: Mooranian, Armin, et al.
Published: (2014)

An optimized probucol microencapsulated formulation integrating a secondary bile acid (deoxycholic acid) as a permeation enhancer
by: Mooranian, Armin, et al.
Published: (2014)

Stability and Release Kinetics of an Advanced Gliclazide-Cholic Acid Formulation: The Use of Artificial-Cell Microencapsulation in Slow Release Targeted Oral Delivery of Antidiabetics
by: Mooranian, Armin, et al.
Published: (2014)

Novel chenodeoxycholic acid-sodium alginate matrix in the microencapsulation of the potential antidiabetic drug, probucol. An in vitro study
by: Mooranian, A., et al.
Published: (2015)

Release and swelling studies of an innovative antidiabetic-bile acid microencapsulated formulation, as a novel targeted therapy for diabetes treatment
by: Mooranian, Armin, et al.
Published: (2015)

Potentials and Limitations of Bile Acids in Type 2 Diabetes Mellitus: Applications of Microencapsulation as a Novel Oral Delivery System
by: Negrulj, Rebecca, et al.
Published: (2013)

Novel artificial cell microencapsulation of a complex gliclazide-deoxycholic bile acid formulation: A Characterization Study
by: Mooranian, Armin, et al.
Published: (2014)

Release and swelling studies of an innovative antidiabetic-bile acid microencapsulated formulation, as a novel targeted therapy for diabetes treatment (vol 32, pg 151, 2014)
by: Mooranian, A., et al.
Published: (2015)

An in vivo pharmacological study: Variation in tissue-accumulation for the drug probucol as the result of targeted microtechnology and matrix-acrylic acid optimization and stabilization techniques
by: Mooranian, Armin, et al.
Published: (2019)

Microencapsulation of Betacyanin extract from amaranth
by: Chong, Pik Han
Published: (2015)

Microencapsulation of Bifidobacterium pseudocatenulatum G4 using natural matrices
by: Abdul Khalil, Khalilah
Published: (2012)

Swelling, mechanical strength, and release properties of probucol microcapsules with and without a bile acid, and their potential oral delivery in diabetes
by: Negrulj, R., et al.
Published: (2015)

Novel artificial cell microencapsulation of probucol and bile acids in diabetes mellitus
by: Mooranian, Armin
Published: (2018)

Inflammatory bowel disease: clinical aspects and treatments
by: Fakhoury, M., et al.
Published: (2014)

Microencapsulated Nigella sativa L. oil as functional ingredient for non-dairy creamer
by: Mohammed, Nameer Khairullah
Published: (2018)

Synthesis and biological evaluation of curcumin-like diarylpentanoid analogues for anti-inflammatory, antioxidant and anti-tyrosinase activities
by: Ka-Heng, Lee, et al.
Published: (2009)

Pharmacological effects of nanoencapsulation of human-based dosing of probucol on ratio of secondary to primary bile acids in gut, during induction and progression of type 1 diabetes
by: Mooranian, Armin, et al.
Published: (2018)

An advanced microencapsulated system: a platform for optimized oral delivery of antidiabetic drug-bile acid formulations
by: Mooranian, A., et al.
Published: (2015)

The effect of a tertiary bile acid, taurocholic acid, on the morphology and physical characteristics of microencapsulated probucol: potential applications in diabetes: a characterization study
by: Mooranian, A., et al.
Published: (2015)

Eudragit®-based microcapsules of probucol with a gut-bacterial processed secondary bile acid
by: Mooranian, A., et al.
Published: (2018)

Effect of microencapsulation efficiency of maltodextrin produced from breadfruit and broken rice and its in vitro wound healing efficacy
by: Mohamed Amin, Zahiah
Published: (2015)

Novel nano-encapsulation of probucol in microgels: scanning electron micrograph characterizations, buoyancy profiling, and antioxidant assay analyses
by: Mooranian, A., et al.
Published: (2018)

Antioxidative, Antihypertensive and Antidiabetic Activities of Cocoa Autolysates Using in Vitro Models
by: Hosseinpoursarmadi, Bahareh
Published: (2011)

Properties of alginate-chitosan microcapsule containing tocotrienols in self-assembled pickering emulsion and its stability in yogurt
by: Tan, Phui Yee
Published: (2017)

Influence of light intensity and temperature on antioxidant activity in Premna serratifolia L
by: Chua, I.Y.P, et al.
Published: (2015)

Long-term probucol therapy continues to suppress markers of neurovascular inflammation in a dietary induced model of cerebral capillary dysfunction
by: Takechi, Ryu, et al.
Published: (2014)

Optimization of spray-drying process conditions for the production of maximally viable microencapsulated L. acidophilus NCIMB 701748
by: Behboudi-Jobbehdar, Solmaz, et al.
Published: (2013)

Characterization of a novel bile acid-based delivery platform for microencapsulated pancreatic ß-cells.
by: Mooranian, Armin, et al.
Published: (2014)

The biological effects of the hypolipidaemic drug probucol microcapsules fed daily for 4 weeks, to an insulin-resistant mouse model: potential hypoglycaemic and anti-inflammatory effects
by: Mooranian, Armin, et al.
Published: (2018)

Development of microencapsulated phase change material with poly (methyl methacrylate) shell for thermal energy storage
by: Su, Weiguang, et al.
Published: (2019)

Development of microencapsulated phase change material for solar thermal energy storage
by: Su, Weiguang, et al.
Published: (2017)

Encapsulation of tamoxifen and magnetic nanoparticles in poly lactic acid using supercritical antisolvent process
by: Alias, Dalila
Published: (2020)

Multicompartmental, multilayered probucol microcapsules for diabetes mellitus: Formulation characterization and effects on production of insulin and inflammation in a pancreatic ß-cell line
by: Mooranian, A., et al.
Published: (2015)

Viability and topographical analysis of microencapsulated ß-cells exposed to a biotransformed tertiary bile acid: An ex vivo study
by: Mooranian, Armin, et al.
Published: (2016)

Optimization of Freeze-Drying Protectants by Response Surface Methodology and Encapsulation for Bifidobacterium Pseudocatenulatum G4 and Lactobacillus Acidophilus LA-5 Survival Enhancement
by: Teoh, Peck Lian
Published: (2011)

Optimization of process conditions and emulsion composition, and their effects on emulsion and encapsulation properties of spray-dried fish oil powder
by: Tirgar, Mina
Published: (2012)

Preparation of microencapsulated phase change materials (MEPCM) for thermal energy storage
by: Su, Weiguang, et al.
Published: (2017)

High-Loading Dose of Microencapsulated Gliclazide Formulation Exerted a Hypoglycaemic Effect on Type 1 Diabetic Rats and Incorporation of a Primary Deconjugated Bile Acid, Diminished the Hypoglycaemic Antidiabetic Effect
by: Golocorbin-Kon, S., et al.
Published: (2017)

Antidiabetic and antioxidant potentials of commercial and traditional bran extracts of Malaysian rice varieties
by: Sadiq, Tanko Abubakar
Published: (2016)

Diabetes development increased concentrations of the conjugated bile acid, taurocholic acid in serum, while treatment with microencapsulated-taurocholic acid exerted no hypoglycaemic effects
by: Mathavan, S., et al.
Published: (2017)

Cannot write session to /tmp/vufind_sessions/sess_pqfcms27aqup3br1i2geqifjqo